Reference
Research peptide guides
Clear, science-led explanations written for researchers. What each compound is, what the published literature examines, and how the paperwork works. Every guide is framed for in-vitro laboratory research use only.
Start here · 7 min read
Are peptides legal in the UK?
An overview of how UK medicines law treats research peptides, what research use only means legally, and why this guide is information rather than legal advice.
Read the guide- Legal
Are peptides legal in the US? (2026 FDA status)
Where BPC-157, TB-500, GHK-Cu, KPV and NAD+ stand with the FDA in 2026: the 503A compounding categories, the July 2026 advisory committee vote, the October 2026 interim access policy, research use only sales and what is still pending.
8 MIN READ - Legal
Are peptides legal in Australia? (2026 TGA status)
How the TGA treats BPC-157, TB-500, GHK-Cu and other peptides in 2026: prescription-only scheduling, the June 2026 compliance priority and joint statement, seizures and court action, and what that means for buyers.
7 MIN READ - Legal
Peptide regulation tracker 2026: FDA, MHRA, TGA updates
A dated, sourced timeline of peptide regulation in the US, UK and Australia from 2023 to October 2026: FDA compounding categories and the July 2026 advisory votes, MHRA enforcement, the TGA's 2026 peptide crackdown and the WADA Prohibited List.
10 MIN READ - Legal
Is BPC-157 legal? US, UK and Australia status (2026)
The legal status of BPC-157 in the US, UK and Australia as of October 2026: the FDA's Category 2 history and July 2026 advisory vote, UK medicines law, Australia's Schedule 4 listing, and its WADA S0 status.
8 MIN READ - Legal
Is TB-500 legal? US, UK and Australia status (2026)
The legal status of TB-500, the synthetic thymosin beta-4 fragment, in the US, UK and Australia as of October 2026, plus its WADA S2 status and what the July 2026 FDA advisory vote did and did not change.
7 MIN READ - Legal
Is GHK-Cu legal? Topical vs injectable status (2026)
GHK-Cu legal status in the US, UK and Australia as of October 2026, separating topical cosmetic copper tripeptide-1 from injectable GHK-Cu, with the FDA's 2026 category changes, the TGA's enforcement priority and WADA status.
8 MIN READ - Legal
Is KPV legal? US, UK and Australia status (2026)
The legal status of the tripeptide KPV in the US, UK and Australia as of October 2026: FDA Category 2 history, the July 2026 advisory vote, UK medicines law, Australia's rules on unapproved peptides and where KPV stands in sport.
7 MIN READ - Legal
Is NAD+ injection legal? US, UK and Australia (2026)
Where NAD+ injections and IV infusions stand legally in the US, UK and Australia in October 2026: FDA compounding Category 1, UK unlicensed medicines rules, the TGA's NAD alert, and WADA's 100 mL infusion limit.
7 MIN READ - Legal
Is MOTS-c legal? US, UK and Australia status (2026)
MOTS-c legal status in the US, UK and Australia as of October 2026: its FDA Category 2 history and 7-5 advisory vote in July 2026, UK medicines law, Australia's unapproved peptide rules and its named WADA S4 listing.
7 MIN READ - Legal
Are peptides banned in sport? WADA 2026 status
Which peptides are banned under the 2026 WADA Prohibited List and why: S0 non-approved substances, S2 peptide hormones and growth factors, S4 metabolic modulators, the infusion rule, the 2027 change, and NCAA, USADA, UKAD and Sport Integrity Australia guidance.
9 MIN READ - Legal
Is It FDA Approved? Peptide Status Chart 2026 - Only Elamipretide Has an Approval
FDA, MHRA, TGA and WADA status for 10 compounds in one table, as of October 2026. Only elamipretide (SS-31, as Forzinity) is FDA approved, for Barth syndrome. BPC-157, TB-500 and KPV won 8-6 PCAC votes and MOTS-c 7-5 in July 2026, with rulemaking pending; BPC-157 and TB-500 are Schedule 4 in Australia; WADA names BPC-157 (S0), TB-500 (S2.3) and MOTS-c (S4.4.1).
7 MIN READ